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Endochondral ossification (EO), by which long bones of the axial skeleton form, is a 
tightly regulated process involving chondrocyte maturation with successive stages of 
proliferation, maturation, and hypertrophy, accompanied by cartilage matrix synthesis, 
calcification, and angiogenesis, followed by osteoblast-mediated ossification. This 
developmental sequence reappears during fracture repair and in osteoarthritic etiopa-
thology. These similarities suggest that EO, and the cells involved, are of great clinical 
importance for bone regeneration as it could provide novel targeted approaches to 
increase specific signaling to promote fracture healing, and if regulated appropriately in 
the treatment of osteoarthritis. The long-held accepted dogma states that hypertrophic 
chondrocytes are terminally differentiated and will eventually undergo apoptosis. In this 
mini review, we will explore recent evidence from experiments that revisit the idea that 
hypertrophic chondrocytes have pluripotent capacity and may instead transdifferentiate 
into a specific sub-population of osteoblast cells. There are multiple lines of evidence, 
including our own, showing that local, selective alterations in cartilage extracellular 
matrix (ECM) remodeling also indelibly alter bone quality. This would be consistent with 
the hypothesis that osteoblast behavior in long bones is regulated by a combination of 
their lineage origins and the epigenetic effects of chondrocyte-derived ECM which they 
encounter during their recruitment. Further exploration of these processes could help to 
unlock potential novel targets for bone repair and regeneration and in the treatment of 
osteoarthritis.
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inTRODUCTiOn
The mobility provided by a robust locomotor skeletal system is a major determinant of human health 
and quality of life. Loss of mobility is a leading cause of ill-health and ultimately death. Two com-
mon skeletal problems include defective bone healing and osteoarthritis (OA); despite increasing 
incidence their treatment remains unmodified for many years (Woolf and Pfleger, 2003; Hunter 
et al., 2014). Their scale is huge; some 1:25 people suffers a bone fracture each year and prevalence in 
the aged reaches 50%, yet as many as 20% do not heal (Johnell and Kanis, 2005). Large bone defects 
resulting from tumor resection add to this population. In these patients, sites from which bone is 
harvested often require follow-up surgery. The greatest mobility failure, however, arises from OA a 
painful, disabling syndrome affecting one third of those >65 years and many younger people. Despite 
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its extensive impact, OA treatment options remain palliative and 
conclude most often in joint replacement. These two problems 
are inextricably linked by cartilage and bone pathology, repair, 
and development.
Bone is not only essential for locomotion, support, and 
protection but crucial for many aspects of health. Specifically, 
bone is a calcium/phosphorous reservoir, is integral to glucose 
metabolism, houses the hematopoietic system and cross-talks 
with renal and reproductive systems. During development, 
ossification of the entire post-cranial, endochondral skeleton 
throughout ontogeny, growth and evolution relies entirely on 
chondrocytes and the specific extracellular matrix (ECM) they 
secrete. The continuous transition of cartilage to bone in this 
endochondral ossification (EO) process is the source of all longi-
tudinal bone growth. A distinct osteoblast cell type is responsible 
for shaping and maintaining bone formation upon this cartilage 
ECM template. Of course, some bones arise intramembranously, 
wherein embryonic mesenchymal cell condensations differenti-
ate directly into osteoprogenitor cells and later into osteoblasts 
(OB), which secrete an unmineralized osteoid bone matrix 
around blood vessels. The compact layer of mesenchymal cells 
surrounding the skeletal element becomes the periosteum; 
OB on its inner surface deposit osteoid to form layers of bone 
(Hall, 2005).
Endochondral ossification is initiated by migration of mes-
enchymal cells to form pre-cartilage condensations, which then 
undergo differentiation into chondrocytes that secrete ECM rich 
in aggrecan (Acan) and collagen type II. Calcification of this 
cartilaginous ECM in this primary ossification center is rapidly 
followed by its partial replacement and use as a template upon 
which bone is deposited by OB. This process involves the “pro-
pulsion” of the growth plate toward the epiphysis by a burst of 
proliferation, column formation followed by differentiation into 
pre-, early- and late, “terminally” differentiated, hypertrophic 
chondrocytes, associated with an increase in cell volume and 
deposition of their transient, calcified cartilage matrix (Ballock 
and O’keefe, 2003; Provot and Schipani, 2005; Mackie et  al., 
2008). The growing cartilage is invaded by blood vessels (Zelzer 
et al., 2002), leading to infiltration of bone-resorbing osteoclasts 
and OB, and ultimately cartilage matrix resorption and new bone 
formation ensue. Resorption at the chondro-osseous interface 
leaves calcified cartilage spicules on which OB deposit osteoid 
to form the primary trabecular bone spongiosa. EO spreads 
longitudinally from this primary center toward the bone ends 
and eventually a secondary ossification center forms, retaining 
the cartilaginous growth plate between each epiphysis and the 
primary ossification center (Figure 1) (Mackie et al., 2008).
In the context of bone healing, these EO processes are 
critically important in bridging the bone defect with a cartilage 
template that is later replaced by bone. Impaired bone healing 
is characterized by failure to undergo full EO in the cartilage 
tissue that is formed. In OA, in contrast, there is a failure to 
retain the stability of the articular cartilage at the joint’s surface, 
which itself is required to sustain the mechanical environment 
required for healthy joint motion. Instead, it exhibits undesirable 
EO-like characteristics during which articular cartilage becomes 
vascularized, mineralized, and eventually replaced by bone 
(Kawaguchi, 2008). This EO is particularly evident at the joint 
margins where osteophytes—bony outgrowths—are formed 
(Pottenger et al., 1990; Boegård et al., 1998). It may also charac-
terize the bone-marrow lesions now established as another OA 
hallmark (Felson et  al., 2001; Kuttapitiya et  al., 2017). Despite 
clear intimacy of this chondro-osseous interplay in growth, bone 
healing and OA, the mechanisms reinforcing the chondrocyte: 
osteoblast inter-relationship are incompletely defined.
An example, relates to the fate of the terminally differenti-
ated chondrocytes. Historically, numerous studies have pro-
vided evidence that these hypertrophic chondrocytes undergo 
apoptosis as their final inevitable fate (Farnum and Wilsman, 
1987, 1989; Gibson et  al., 1995; Zenmyo et  al., 1996; Aizawa 
et al., 1997; Gibson, 1998). The molecular mechanisms are not 
fully elucidated but molecular apoptotic signatures; activation 
of caspases and decreased expression of anti-apoptotic fac-
tor Bcl-2, have been reported in hypertrophic chondrocytes 
(Amling et al., 1997; Adams and Shapiro, 2002). Until recently, 
consensus was also that all OB originated from invading, 
periosteal-derived osteoprogenitor cells (Colnot et  al., 2004; 
Maes et al., 2010). Remarkably, hypertrophic chondrocytes lack 
morphological characteristics of apoptosis; which challenges 
earlier reports (Emons et al., 2009; Carames et al., 2010) as it 
would be expected that cell chromatin condensation and nuclear 
fragmentation would readily be visible. Instead, the presence of 
autophagic vacuoles and expression of autophagy-regulating 
genes by growth plate chondrocytes suggest that they instead 
undergo processes resembling autophagy (Roach and Clarke, 
2000; Shapiro et al., 2005).
It is clear nonetheless that these EO-related events are regu-
lated by paracrine and endocrine signals (Day et  al., 2005) 
including ECM constituents and ECM-modifying enzymes 
[matrix metalloproteinases (MMPs)] and their regulators (tissue 
inhibitors of MMPs; TIMPs) (Murphy and Nagase, 2008). Herein, 
we will (i) explore recent evidence that revisits the idea that 
hypertrophic chondrocytes may transdifferentiate into a specific 
sub-population of osteoblast cells and (ii) share data suggesting 
that osteoblast behavior in this sub-population relies partly 
upon a direct contribution from the cartilage ECM composition. 
There are multiple lines of evidence, including our own, show-
ing that local, selective alterations in cartilage ECM remodeling 
indelibly alter bone quality. This would be consistent with the 
hypothesis that osteoblast behavior in long bones is regulated by 
a combination of their lineage origins and the epigenetic effects 
of chondrocyte-derived ECM which they encounter during their 
recruitment (Figure 2).
eMeRGenCe OF A CHOnDRO-OSSeOUS 
CeLLULAR COnTinUUM
Endochondral ossification is predominantly understood through 
its function in long bone development, where mesenchymal-
derived chondrocytes undergo a multistep process. These steps 
correspond to phases in which a precursor pool is maintained, an 
expansion in cell number, a halt upon division, entry into differ-
entiation and matrix production and finally a dramatic increase 
FiGURe 1 | Schematic of endochondral ossification and formation of primary and secondary ossification centers.
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in size occur (Tsang et al., 2015). Hypertrophic chondrocytes are 
often characterized by expression of MMP-13, type X collagen 
and vascular endothelial growth factor (VEGF) that are hall-
marks of their terminal maturation status. It has been assumed 
that these hallmarks precede their apoptotic death (Farnum and 
Wilsman, 1987, 1989; Gibson et al., 1995; Zenmyo et al., 1996; 
Aizawa et  al., 1997; Amling et  al., 1997; Gibson, 1998; Adams 
and Shapiro, 2002), which heralds the replacement of cartilage 
by bone that is initiated by OB and accompanied by vascular 
invasion of the ECM (Ortega et al., 2004).
An alternative fate and a question that was originally posed 
more than a century ago (Vander Stricht, 1890; Brachet, 1893) 
was: can hypertrophic chondrocytes “recycle,” become OB and, 
therefore, contribute to the osteogenic lineage? This alterna-
tive theory has for a long time been a source of controversy. 
Initially, Dodds and Cameron used histological analysis in rats 
with rickets to suggest that cartilage cells undergo a form of 
differentiation that facilitates their eventual transition into 
osteocytes (Dodds and Cameron, 1939). Consistent with these 
suggestions, recent studies using a range of in vivo and in vitro 
strategies have demonstrated that hypertrophic chondrocytes 
can traverse this chondro-osseous interface to persist as OB 
and endorse their ultimate osteocytogenesis to assume a master 
bone-regulatory function. These studies indicate that newly 
transdifferentiated OB populate both trabecular and mature 
cortical bone.
FiGURe 2 | Schematic of hypothesis. (A) Normal cartilage extracellular 
matrix (ECM) (blue) as template for successful (pink) bone formation by 
osteoblasts (OB) derived either from chondrocytes (Chondro-OB, beige, red 
outline) or from bone-marrow progeny (BM-OB, green); (B) Modified ECM 
(gray texturized) produced by TIMP3 Tg chondrocytes (gray, red outline) as 
template for defective bone formation by Chondro-OB (gray, red outline).
4
Javaheri et al. The Emergence of the Chondro-Osseous Continuum
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org March 2018 | Volume 6 | Article 28
A number of studies explored this alternative fate further; 
Yoshioka and Yagi (1988) found hypertrophic chondrocytes 
within primary spongiosa of the rat mandibular condylar 
cartilage. In addition, Roach and others (Roach, 1992; Roach 
et  al., 1995; Erenpreisa and Roach, 1996) reported asymmetric 
hypertrophic chondrocyte division in chick bones with one 
daughter cell transdifferentiating into an osteoblast and the other 
experiencing apoptosis. Several other studies reported, even in 
the absence of direct evidence for transdifferentiation, that hyper-
trophic chondrocytes and OB share many similarities including 
an osteogenic-specific gene expression profile; both express 
alkaline phosphatase, osteonectin, osteocalcin, osteopontin, and 
bone sialoprotein; suggesting common origins (Silbermann et al., 
1983; Moskalewski and Malejczyk, 1989; Thesingh et  al., 1991; 
Cancedda et al., 1992; Roach, 1992; Galotto et al., 1994; Roach 
et al., 1995; Gerstenfeld and Shapiro, 1996; Riminucci et al., 1998; 
Enishi et al., 2014).
Survival of hypertrophic chondrocytes during EO was 
found in pathology; chondrocytes in fracture repair calluses 
exhibited transdifferentiation to OB contributing to ossification. 
Convincing experimental evidence for a continuous chondrocyte- 
to-osteoblast lineage also came from use of a cell specific, tamo-
xifen inducible genetic recombination approach, where chon-
drocytes from the cartilage anlagen/growth plate were found as 
OB forming new bone, contributing to fracture repair (Zhou 
et  al., 2014). This conclusion was supported by results from 
Yang et  al., who used Col10a1 driven Cre/loxP to specifically 
target and tag hypertrophic chondrocytes in vivo to report that 
a hypertrophic chondrocyte sub-population expressing Col10a1 
transform into Col1a1-expressing OB and mature osteocytes that 
express SCLEROSTIN, pre-/post-natally and during fracture 
repair (Yang et al., 2014). These OB, like those derived directly 
from osteoblast progenitors, potentially participate in other 
pathological states including OA. It is reasonable to postulate 
that any inherent chondrocytic defect could ultimately impact 
the behavior of their resulting bone cells and thus, that any gene 
expressed by chondrocytes influences this sub-population of 
OB ultimately affecting osteogenesis. Jing et  al. reported that 
targeted cartilage-specific cell lineage-tracing leads not only to 
severe defects in chondrogenesis but complete cessation of EO, 
with absence of cartilage “remnants” in the subchondral bone 
(Jing et al., 2015). More importantly, bone phenotypes should 
now be scrutinized for mutations that also affect cartilage 
(Bahney et al., 2014).
This notion was further supported by an exploration of stem 
cell behaviors in endochondral bone healing, which revealed 
activation of the pluripotent transcription factor, Oct4A—a 
stem cell marker with proposed cell reprogramming roles—in 
vascularizing tissues and hypertrophic chondrocytes (Bahney 
et  al., 2014). Despite poor clarity regarding Oct4A function, 
it appears that chondrocytes dedifferentiate by mechanisms 
resembling those described for induced pluripotent cells, to 
regain progenitor capabilities. This would be consistent with 
mechanism described by Song and Tuan (2004). Elucidation 
of the cellular reprogramming mechanism(s) that direct this 
transition from cartilage to bone is, therefore, an obvious target. 
However, the substantial overlap that exists between markers 
of hypertrophic chondrocytes and OB represent a significant 
hurdle in such elucidation (Lian et al., 1993; Stafford et al., 1994; 
Hughes et al., 1995; Gerstenfeld and Shapiro, 1996). These dif-
ficulties in discerning the reprogramming mechanisms are not 
altogether surprising, since chondrocytes and OB are known to 
share common osteochondral progenitor origins. More recently, 
Wang et  al. found that SHP2, a cytoplasmic protein tyrosine 
phosphatase, modulates chondrocyte-to-osteoblast differen-
tiation and that SHP2 deletion exerts a negative skeletal impact 
(Wang et al., 2017).
Ono et  al. revealed that cells expressing Cre-recombinases 
driven by the collagen II (Col2) promoter/enhancer, and their 
descendants, contributed to osteoblast progenitors before 
Runx2 expression; using inducer Col2-creER, Sox9-creER, 
and Acan-creER approaches these authors reported that early 
postnatal cells progressively contribute to multiple mesenchy-
mal lineages (Ono et al., 2014). Moreover, Enishi et al. reported 
that chondrocytes switch to osteoblast-like cells after vascular 
invasion (Enishi et al., 2014). More recently, Hu et al. described 
a spatially dependent phenotypic overlap between hypertrophic 
chondrocytes and OB at the chondro-osseous border in fracture 
callus, where the former activate expression of the pluripotency 
factors Sox2, Oct4 (Pou5f1), and Nanog (Hu et al., 2017). These 
studies also demonstrated that endothelial cell conditioned 
medium upregulates these genes in ex vivo fracture cultures, 
supporting histological evidence that transdifferentiation 
occurs adjacent to the vasculature. Moreover, Park et al. (2015) 
employed BAC-Col10-Cre deleter mice to activate ROSA26 
LacZ and ROSA26 YFP reporter genes specifically in hyper-
trophic chondrocytes (Gebhard et  al., 2008). They found that 
BAC-Col10-Cre;ROSA26 driven LacZ and YFP expression was 
restricted to hypertrophic chondrocytes before primary ossifi-
cation center formation, but that substantial osteoblast numbers 
were positive for β-gal or YFP after onset of bone-marrow for-
mation, leading to the proposal that these OB originated from 
Col10a1-expressing chondrocytes. This work further revealed 
the existence of a population of hypertrophic chondrocytes 
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close to the chondro-osseous junction that express stem cell 
and osteoblast markers (Park et al., 2015). In addition, Jing et al. 
(2015), using cartilage-specific cell lineage–tracing in mice con-
taining ROSA 26tdTomato, 2.3 Col1GFP, and Acan CreERT2 or 
Col10-Cre reported that hypertrophic chondrocytes collectively 
expressed high levels of the anti-apoptotic protein, BCL2. 
In addition, alkaline phosphatase immunoreactivity was strong 
in hypertrophic chondrocytes, and BrdU data showed that some 
hypertrophic chondrocytes undergo cell division. Thus, hyper-
trophic chondrocytes resemble metabolically active OB rather 
than simply being inert, metabolically inactive cells, waiting 
to undergo apoptosis (Jing et  al., 2015). These novel findings 
suggest that, at least, some OB originate from a source distinct 
from the periosteal-derived osteoprogenitors. Might OB with 
distinct origins vary in their behavior and activity?
We previously investigated whether OB with divergent origins 
from different bone types exhibit divergence in their behavior, 
by comparing growth, differentiation, and angiogenic potential 
of OB derived from structurally distinct subchondral, trabecular, 
and cortical bone from a singular skeletal vicinity (Clarkin and 
Olsen, 2010; Shah et al., 2015). We found that OB from trabecu-
lar bone showed slower proliferation, but higher RUNX2, SP7 
and BSP-II mRNA levels, TNAP mRNA and protein activity, 
and lower TNFRSF11B:TNFSF11 mRNA ratios compared to 
subchondral and cortical bone. In contrast, subchondral OB 
showed higher VEGF-A mRNA and protein release, implying 
more intimate vascular relationships (Shah et  al., 2015). These 
findings are consistent with data showing that the response of 
trabecular, cortical, and subchondral bone to in vivo challenges 
is not always identical (Lavigne et al., 2005; Wade-Gueye et al., 
2012), with distinct transcriptional signatures in OB from long 
bone and calvaria (Akintoye et al., 2006; Rawlinson et al., 2009) 
and with OB displaying differing gene transcription depending 
on anatomical location (Candeliere et al., 2001). These data raise 
the possibility that osteoblast behaviors reflect progenitor origins 
related to the crossing of a chondro-osseous continuum.
The clearly strong relationships between cells of the growth 
plate, OB and the vasculature have been dealt with elegantly 
elsewhere (Maes, 2013). With particular relevance to the con-
cepts shared herein, it is important that we highlight changes 
to ECM-modifying proteins have been shown to modify vas-
cularization pre- and post-natally. Previous studies have shown 
that disruption of matrix remodeling via modification in MMPs 
leads to delayed vascularization, inefficient bone repair, and sig-
nificant alteration in bone mass and architecture (Vu et al., 1998; 
Holmbeck et  al., 1999; Zhou et  al., 2000; Colnot et  al., 2003; 
Stickens et al., 2004; Behonick et al., 2007; Lieu et al., 2011). Does 
this show that the behavior of OB derived from chondrocytes 
is determined by the cartilage ECM they encounter?
DO MODiFiCATiOnS in THe CHOnDRO-
OSSeOUS eCM ePiGeneTiCALLY 
MODiFY OSTeOBLAST BeHAviOR?
The ECM is a powerful driver of cell behavior. ECM–cell rela-
tionships are tightly conserved across evolution, highly dynamic 
and extend beyond mechanical control of cell fate. Defining how 
ECM “messages” guide cell performance provides translational 
impact for stem cell biologists, tissue engineers and biologists 
to transform approaches to regenerate, repair and remodel con-
nective tissue across pathophysiological contexts. The ECM of 
the growth plate represents an alternative stimulus to regulate 
the behavior of cells crossing this chondro-osseous continuum, 
demonstrating the full intimacy of chondrocyte-osteoblast 
interplay.
Bone quality and functional integrity relies on interplay 
between resident cells and the cartilage ECM template. Evidence 
for this is strong; local control of cartilage ECM remodeling has 
down-stream effects on bone formation, with mice deficient in 
the MMPs and TIMP3 having severely disrupted growth plate 
ECM and bone defects (Vu et al., 1998; Holmbeck et al., 1999; 
Zhou et al., 2000; Stickens et al., 2004; Javaheri et al., 2016). Does 
this show that osteoblast behavior is determined by the cartilage 
ECM they encounter? It seems likely as expression of factors 
crucial to cartilage signaling (Indian hedgehog, patched and 
parathyroid hormone-related peptide) are not modified (Karaplis 
et  al., 1994; Marigo et  al., 1996; Vortkamp et  al., 1996; Maeda 
et al., 2007). Furthermore, selective chondrocyte-specific Sox9-
Cre mediated loss of disintegrin and metallopeptidase domain 
containing enzyme (ADAM17) leads to bone defects without 
modifying intrinsic proliferation of resident chondrocytes. 
Thus, chondrocyte ECM, not solely humoral factors or growth 
plate dynamics may guide bone mass, architecture, and function 
(Javaheri et al., 2016).
To test this hypothesis, we created mice with severely modi-
fied cartilage ECM remodeling by targeting TIMP3, a member 
of the metzincin family of MMP inhibitors that inhibits a wide 
spectrum of ECM-modifying enzymes. Our work in TIMP3-
deficient mice and mice overexpressing TIMP3 specifically 
in chondrocytes, via a collagen type II promoter/enhancer 
(TIMP3 Tg) reveals (i) transient long bone shortening that 
is restored before adulthood; (ii) diminished bone mass with 
defective architecture and lower fracture resistance; (iii) restric-
tion of TIMP3 Tg impact to only endochondral bones; and 
(iv) deficiencies in osteoblast proliferation and differentiation 
that persists in vitro. Our data show that bone formation relies 
partly upon the cartilage ECM encountered during osteoblast 
recruitment (Javaheri et al., 2016; Poulet et al., 2016). Our work 
also shows that aggrecanase inhibition increases and collagenase 
inhibition decreases bone mass, suggesting that balance in their 
activities is crucial; however, the identities of the growth plate 
ECM components that underpin these divergent phenotypes 
remains obscure.
While our findings confirm the existence of a cellular chon dro-
osseous continuum, they also crucially pinpoint how behavior of 
cells with divergent origins is controlled in vivo by the ECM they 
encounter. Since growth plate calcified cartilage serves as a tem-
plate not only for bone formation but also osteoclast-mediated 
resorption, this implies that osteoclast behavior may also be 
modified in TIMP3 Tg mice to subsequently influence bone 
formation. However, our pilot studies suggest this is unlikely as 
we find no significant changes in osteoclast numbers in TIMP3 
Tg mouse bone (Javaheri et al., 2016). In contrast, we find that 
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OB derived from these TIMP3 Tg mice have defective differentia-
tion even upon in vitro isolation, supporting the likelihood that 
“imprinted” epigenetic modifications are contingent upon the 
ECM the OB encounter (Poulet et al., 2016). The precise nature 
of these epigenetic effects of chondrocyte-derived ECM remains 
unexplored. Nonetheless, multiple lines of evidence, including 
ours, show that local alterations in cartilage ECM remodeling 
indelibly alter bone quality, leading us to hypothesize that osteo-
blast behavior in long bones is regulated by a combination of their 
lineage origins and the epigenetic effects of chondrocyte-derived 
ECM they encounter during recruitment.
COnCLUSiOn
Recent evidence challenges a long-held paradigm regarding 
EO, indicating that chondrogenesis and osteogenesis are more 
closely linked than appreciated and, that cells derived originally 
from the cartilage niche, as opposed to solely osteoprogenitors, 
transform into bone-forming OB and ultimately osteocytes. We 
offer a fundamental extension to this paradigm proposing that 
these OB are epigenetically influenced by ECM encountered 
during this transition. We need to ascertain how hypertrophic 
chondrocyte transdifferentiation fate is controlled and which 
specific ECM factors regulate this transition to impact bone 
quality and integrity. This new concept challenges us to re-
evaluate cartilage and bone stages in EO, such that we treat 
them as a continuum rather than entirely independent. It also 
prompts us to revisit EO as an “evolutionary” shift in which 
cartilage might provide new cells that can instead form bone 
rather than simply as a means of lengthening skeletal elements. 
As impaired bone healing and OA both involve EO it is con-
ceivable that tissue engineering approaches might exploit these 
developmental principles, embracing the newly established 
cellular chondro-osseous continuum to better control cell fate 
decisions.
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